FoldRx Pharmaceuticals •  Cambridge, MA
Laboratory, Office & Animal Facility Buildout
Architect: Olson Lewis Dioli & Doktor Architects | Manchester-by-the-Sea, MA


To accommodate the need for a flexible facility that could grow with the expanding scope of its operations, FoldRx leased approximately 14,000 sf of shell space in an occupied building at Discovery Park in Cambridge.

As construction manager, PIDC was called on execute and augment the program developed by architect — while providing a cost-effective design/build solution for the MEP/FP scope of work. Upon completion of the design documents, PIDC managed the fast-track fitout of the laboratories, animal care facilities, support space and offices to meet the owner’s occupancy milestone.

Project highlights include:

  • The challenge of fitting out 14,000 sf of shell space, located on the fifth floor of an occupied building.
  • New biology and tissue culture labs, along with a radioisotope hot lab
  • A state-of-the-art animal care facility
  • High-end corporate offices and support space
  • Special MEP requirements for leading-edge research including a new once-through AHU for the new labs, a backup AHU for the animal care facility, along with pH and acid neutralization systems.

FoldRx Pharmaceuticals is a drug discovery and development company focused on first-in-class, disease-modifying small molecule therapeutics to modify and treat diseases caused by protein misfolding. Now a wholly owned subsidiary of Pfizer, Inc., its development portfolio has included therapeutic agents for the treatment of ATTR-PN, cystic fibrosis, Parkinson’s disease and Huntington’s disease.

Owner Contact:
Chris Adams, Chief Business Officer
617.252.5502  •  cadams@foldrx.com